BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 26725251)

  • 1. Limited use of surveillance imaging following nephrectomy for renal cell carcinoma.
    Kim EH; Vetter JM; Kuxhausen AN; Song JB; Sandhu GS; Strope SA
    Urol Oncol; 2016 May; 34(5):237.e11-8. PubMed ID: 26725251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of surveillance imaging after nephrectomy in the Medicare population.
    Feuerstein MA; Atoria CL; Pinheiro LC; Huang WC; Russo P; Elkin EB
    BJU Int; 2016 Feb; 117(2):280-6. PubMed ID: 25382743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging strategy and outcome following partial nephrectomy.
    Mouracade P; Chavali JS; Kara O; Dagenais J; Maurice MJ; Nelson RJ; Rini BI; Kaouk JH
    Urol Oncol; 2017 Nov; 35(11):660.e1-660.e8. PubMed ID: 28863862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
    Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
    Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis.
    Abdollah F; Suardi N; Capitanio U; Matloob R; Fossati N; Castiglione F; Di Trapani E; Di Trapani D; Russo A; Carenzi C; Montorsi F; Rigatti P; Bertini R
    Urol Oncol; 2014 Jan; 32(1):43.e9-16. PubMed ID: 23911684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system.
    Lam JS; Shvarts O; Leppert JT; Pantuck AJ; Figlin RA; Belldegrun AS
    J Urol; 2005 Aug; 174(2):466-72; discussion 472; quiz 801. PubMed ID: 16006866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal cell carcinoma: presentation, staging, and surgical treatment.
    Russo P
    Semin Oncol; 2000 Apr; 27(2):160-76. PubMed ID: 10768595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of Pelvic CT for Surveillance of T2-T4 Renal Cell Carcinoma After Nephrectomy With Curative Intent.
    Kaiser A; Davenport MS; Hafez KS; Alva A; Bailey JJ; Francis IR
    AJR Am J Roentgenol; 2018 May; 210(5):1088-1091. PubMed ID: 29489406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Usefulness of Chest X-Rays for T1a Renal Cell Carcinoma Surveillance.
    Canvasser NE; Stouder K; Lay AH; Gahan JC; Lotan Y; Margulis V; Raj GV; Sagalowsky AI; Cadeddu JA
    J Urol; 2016 Aug; 196(2):321-6. PubMed ID: 26880407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy.
    Stephenson AJ; Chetner MP; Rourke K; Gleave ME; Signaevsky M; Palmer B; Kuan J; Brock GB; Tanguay S
    J Urol; 2004 Jul; 172(1):58-62. PubMed ID: 15201737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cell carcinoma: evaluation of the 1997 TNM system and recommendations for follow-up after surgery.
    Gofrit ON; Shapiro A; Kovalski N; Landau EH; Shenfeld OZ; Pode D
    Eur Urol; 2001 Jun; 39(6):669-74; discussion 675. PubMed ID: 11464056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Empiric Evaluation of the Effect of Variation in Intensity of Followup for Surgically Treated Renal Neoplasms on Cancer Specific Survival.
    Sohn W; Graves AJ; Tyson MD; O'Neil B; Chang SS; Ni S; Barocas DA; Penson DF; Resnick MJ
    J Urol; 2017 Jan; 197(1):37-43. PubMed ID: 27575607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of surveillance imaging following treatment of small renal masses.
    Kowalczyk KJ; Harbin AC; Choueiri TK; Hevelone ND; Lipsitz SR; Trinh QD; Tina Shih YC; Hu JC
    J Urol; 2013 Nov; 190(5):1680-5. PubMed ID: 23764074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant variability in 10-year cumulative radiation exposure incurred on different surveillance regimens after surgery for pT1 renal cancers: yet another reason to standardize protocols?
    Lin YK; Gettle L; Raman JD
    BJU Int; 2013 May; 111(6):891-6. PubMed ID: 23331317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axial Abdominal Imaging after Partial Nephrectomy for T1 Renal Cell Carcinoma Surveillance.
    Sorokin I; Canvasser NE; Margulis V; Lotan Y; Raj G; Sagalowsky A; Gahan JC; Cadeddu JA
    J Urol; 2017 Nov; 198(5):1021-1026. PubMed ID: 28442383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiologic follow-up of patients with T1-3a,b,c or T4N+M0 renal cell carcinoma after radical nephrectomy.
    Saidi JA; Newhouse JH; Sawczuk IS
    Urology; 1998 Dec; 52(6):1000-3. PubMed ID: 9836544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A non-cancer-related survival benefit is associated with partial nephrectomy.
    Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
    Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic radiation exposure during surveillance in patients with pT1a renal cell carcinoma.
    Lipsky MJ; Shapiro EY; Hruby GW; McKiernan JM
    Urology; 2013 Jun; 81(6):1190-5. PubMed ID: 23540857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a role for partial nephrectomy in patients with metastatic renal cell carcinoma?
    Hellenthal NJ; Mansour AM; Hayn MH; Schwaab T
    Urol Oncol; 2013 Jan; 31(1):36-41. PubMed ID: 21396834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.